Fusion Genomics Corporation
ONETest - ONETest Personalized Genomes Medicine
The goal of personalized medicine is to achieve optimal therapy for each patient based on his or her genomic profile. In infectious or host-dependent diseases, this means therapies that also take into account the pathogen’s mutating genotype.
Most popular related searches
genomics
antibiotic resistant
respiratory tracts
pharmaceutical industry
genomic profile
genomic profiling
respiratory tract
antibiotic resistance
vaccine development
genomic medicine
Syndromic Genomic Panels
Respiratory tract infections are caused by a large number of viral, bacterial, and fungal pathogens, which all produce overlapping symptoms. Because many current tests are pathogen specific, they require multiple testings to achieve accurate diagnosis. Even when successful, these tests provide limited genetic information.FUSION GENOMICS is developing a Multiplex Upper Respiratory ONETest™ (MURONTest) based on specifications by Key Opinion Leaders from Canada, EU and the pharmaceutical industry. The test is expected to detect over 25 pathogens with more than 100 subtypes and provide key information on genomic regions of interest for diagnosis, antibiotic resistance, detection of virulent strains and vaccine development.
